Global Biosynthesis of Cannabinoids Market 2024 by Company, Regions, Type and Application, Forecast to 2030

August 2024 | 103 pages | ID: GB301D73F25EEN
GlobalInfoResearch

Abstracts

According to our latest research, the global Biosynthesis of Cannabinoids market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.

Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.

The Biosynthesis of Cannabinoids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Biosynthesis of Cannabinoids market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• THC
• CBD
• Others

Market segment by Application, can be divided into

• Food Industry
• Medical Industry
• Others

Market segment by players, this report covers

• Anandia Laboratories
• Gingko Bioworks
• Hyasynth Bio
• InMed Pharmaceuticals
• Librede
• Renew Biopharma
• Cronos Group
• Organigram
• Teewinot Life Sciences
• ICC International Cannabis Corp.
• Biotii Technologies Corp.
• Bristol-Myers Squibb
• Biogen Inc.
• GW Pharmaceuticals

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Biosynthesis of Cannabinoids product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biosynthesis of Cannabinoids, with recent developments and future plans

Chapter 3, the Biosynthesis of Cannabinoids competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Biosynthesis of Cannabinoids market forecast, by regions, with revenue, from 2024 to 2030.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.

Chapter 7 and 8, to describe Biosynthesis of Cannabinoids research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Biosynthesis of Cannabinoids
1.2 Classification of Biosynthesis of Cannabinoids by Type
  1.2.1 Overview: Global Biosynthesis of Cannabinoids Market Size by Type: 2024 Versus 2030
  1.2.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Type in 2030
  1.2.3 THC
  1.2.4 CBD
  1.2.5 Others
1.3 Global Biosynthesis of Cannabinoids Market by Application
  1.3.1 Overview: Global Biosynthesis of Cannabinoids Market Size by Application: 2024 Versus 2030
  1.3.2 Food Industry
  1.3.3 Medical Industry
  1.3.4 Others
1.4 Global Biosynthesis of Cannabinoids Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Biosynthesis of Cannabinoids Market Drivers
  1.5.2 Biosynthesis of Cannabinoids Market Restraints
  1.5.3 Biosynthesis of Cannabinoids Trends Analysis

2 COMPANY PROFILES

2.1 Anandia Laboratories
  2.1.1 Anandia Laboratories Details
  2.1.2 Anandia Laboratories Major Business
  2.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Product and Solutions
  2.1.4 Anandia Laboratories Recent Developments and Future Plans
2.2 Gingko Bioworks
  2.2.1 Gingko Bioworks Details
  2.2.2 Gingko Bioworks Major Business
  2.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Product and Solutions
  2.2.4 Gingko Bioworks Recent Developments and Future Plans
2.3 Hyasynth Bio
  2.3.1 Hyasynth Bio Details
  2.3.2 Hyasynth Bio Major Business
  2.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Product and Solutions
  2.3.4 Hyasynth Bio Recent Developments and Future Plans
2.4 InMed Pharmaceuticals
  2.4.1 InMed Pharmaceuticals Details
  2.4.2 InMed Pharmaceuticals Major Business
  2.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
  2.4.4 InMed Pharmaceuticals Recent Developments and Future Plans
2.5 Librede
  2.5.1 Librede Details
  2.5.2 Librede Major Business
  2.5.3 Librede Biosynthesis of Cannabinoids Product and Solutions
  2.5.4 Librede Recent Developments and Future Plans
2.6 Renew Biopharma
  2.6.1 Renew Biopharma Details
  2.6.2 Renew Biopharma Major Business
  2.6.3 Renew Biopharma Biosynthesis of Cannabinoids Product and Solutions
  2.6.4 Renew Biopharma Recent Developments and Future Plans
2.7 Cronos Group
  2.7.1 Cronos Group Details
  2.7.2 Cronos Group Major Business
  2.7.3 Cronos Group Biosynthesis of Cannabinoids Product and Solutions
  2.7.4 Cronos Group Recent Developments and Future Plans
2.8 Organigram
  2.8.1 Organigram Details
  2.8.2 Organigram Major Business
  2.8.3 Organigram Biosynthesis of Cannabinoids Product and Solutions
  2.8.4 Organigram Recent Developments and Future Plans
2.9 Teewinot Life Sciences
  2.9.1 Teewinot Life Sciences Details
  2.9.2 Teewinot Life Sciences Major Business
  2.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Product and Solutions
  2.9.4 Teewinot Life Sciences Recent Developments and Future Plans
2.10 ICC International Cannabis Corp.
  2.10.1 ICC International Cannabis Corp. Details
  2.10.2 ICC International Cannabis Corp. Major Business
  2.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product and Solutions
  2.10.4 ICC International Cannabis Corp. Recent Developments and Future Plans
2.11 Biotii Technologies Corp.
  2.11.1 Biotii Technologies Corp. Details
  2.11.2 Biotii Technologies Corp. Major Business
  2.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Product and Solutions
  2.11.4 Biotii Technologies Corp. Recent Developments and Future Plans
2.12 Bristol-Myers Squibb
  2.12.1 Bristol-Myers Squibb Details
  2.12.2 Bristol-Myers Squibb Major Business
  2.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Product and Solutions
  2.12.4 Bristol-Myers Squibb Recent Developments and Future Plans
2.13 Biogen Inc.
  2.13.1 Biogen Inc. Details
  2.13.2 Biogen Inc. Major Business
  2.13.3 Biogen Inc. Biosynthesis of Cannabinoids Product and Solutions
  2.13.4 Biogen Inc. Recent Developments and Future Plans
2.14 GW Pharmaceuticals
  2.14.1 GW Pharmaceuticals Details
  2.14.2 GW Pharmaceuticals Major Business
  2.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
  2.14.4 GW Pharmaceuticals Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Biosynthesis of Cannabinoids Revenue and Share by Players (2024 & 2030)
3.2 Biosynthesis of Cannabinoids Players Head Office, Products and Services Provided
3.3 Biosynthesis of Cannabinoids Mergers & Acquisitions
3.4 Biosynthesis of Cannabinoids New Entrants and Expansion Plans

4 GLOBAL BIOSYNTHESIS OF CANNABINOIDS FORECAST BY REGION

4.1 Global Biosynthesis of Cannabinoids Market Size by Region: 2024 VS 2030
4.2 Global Biosynthesis of Cannabinoids Market Size by Region, (2024-2030)
4.3 North America
  4.3.1 Key Companies of Biosynthesis of Cannabinoids in North America
  4.3.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in North America
  4.3.3 North America Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
4.4 Europe
  4.4.1 Key Companies of Biosynthesis of Cannabinoids in Europe
  4.4.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Europe
  4.4.3 Europe Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
4.5 Asia-Pacific
  4.5.1 Key Companies of Biosynthesis of Cannabinoids in Asia-Pacific
  4.5.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Asia-Pacific
  4.5.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Biosynthesis of Cannabinoids in South America
  4.6.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in South America
  4.6.3 South America Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
4.7 Middle East & Africa
  4.7.1 Key Companies of Biosynthesis of Cannabinoids in Middle East & Africa
  4.7.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Middle East & Africa
  4.7.3 Middle East & Africa Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Biosynthesis of Cannabinoids Market Forecast by Type (2024-2030)
5.2 Global Biosynthesis of Cannabinoids Market Share Forecast by Type (2024-2030)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Biosynthesis of Cannabinoids Market Forecast by Application (2024-2030)
6.2 Global Biosynthesis of Cannabinoids Market Share Forecast by Application (2024-2030)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Biosynthesis of Cannabinoids Revenue by Type, (USD Million), 2024 VS 2030
Table 2. Global Biosynthesis of Cannabinoids Revenue by Application, (USD Million), 2024 VS 2030
Table 3. Anandia Laboratories Corporate Information, Head Office, and Major Competitors
Table 4. Anandia Laboratories Major Business
Table 5. Anandia Laboratories Biosynthesis of Cannabinoids Product and Solutions
Table 6. Gingko Bioworks Corporate Information, Head Office, and Major Competitors
Table 7. Gingko Bioworks Major Business
Table 8. Gingko Bioworks Biosynthesis of Cannabinoids Product and Solutions
Table 9. Hyasynth Bio Corporate Information, Head Office, and Major Competitors
Table 10. Hyasynth Bio Major Business
Table 11. Hyasynth Bio Biosynthesis of Cannabinoids Product and Solutions
Table 12. InMed Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 13. InMed Pharmaceuticals Major Business
Table 14. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
Table 15. Librede Corporate Information, Head Office, and Major Competitors
Table 16. Librede Major Business
Table 17. Librede Biosynthesis of Cannabinoids Product and Solutions
Table 18. Renew Biopharma Corporate Information, Head Office, and Major Competitors
Table 19. Renew Biopharma Major Business
Table 20. Renew Biopharma Biosynthesis of Cannabinoids Product and Solutions
Table 21. Cronos Group Corporate Information, Head Office, and Major Competitors
Table 22. Cronos Group Major Business
Table 23. Cronos Group Biosynthesis of Cannabinoids Product and Solutions
Table 24. Organigram Corporate Information, Head Office, and Major Competitors
Table 25. Organigram Major Business
Table 26. Organigram Biosynthesis of Cannabinoids Product and Solutions
Table 27. Teewinot Life Sciences Corporate Information, Head Office, and Major Competitors
Table 28. Teewinot Life Sciences Major Business
Table 29. Teewinot Life Sciences Biosynthesis of Cannabinoids Product and Solutions
Table 30. ICC International Cannabis Corp. Corporate Information, Head Office, and Major Competitors
Table 31. ICC International Cannabis Corp. Major Business
Table 32. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product and Solutions
Table 33. Biotii Technologies Corp. Corporate Information, Head Office, and Major Competitors
Table 34. Biotii Technologies Corp. Major Business
Table 35. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product and Solutions
Table 36. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 37. Bristol-Myers Squibb Major Business
Table 38. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product and Solutions
Table 39. Biogen Inc. Corporate Information, Head Office, and Major Competitors
Table 40. Biogen Inc. Major Business
Table 41. Biogen Inc. Biosynthesis of Cannabinoids Product and Solutions
Table 42. GW Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. GW Pharmaceuticals Major Business
Table 44. GW Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
Table 45. Global Biosynthesis of Cannabinoids Revenue (USD Million) by Players (2024 & 2030)
Table 46. Global Biosynthesis of Cannabinoids Revenue Share by Players (2024 & 2030)
Table 47. Biosynthesis of Cannabinoids Players Head Office, Products and Services Provided
Table 48. Biosynthesis of Cannabinoids Mergers & Acquisitions in the Past Five Years
Table 49. Biosynthesis of Cannabinoids New Entrants and Expansion Plans
Table 50. Global Market Biosynthesis of Cannabinoids Revenue (USD Million) Comparison by Region (2024 VS 2030)
Table 51. Global Biosynthesis of Cannabinoids Revenue Market Share by Region (2024-2030)
Table 52. Key Companies of Biosynthesis of Cannabinoids in North America
Table 53. Current Situation and Forecast of Biosynthesis of Cannabinoids in North America
Table 54. Key Companies of Biosynthesis of Cannabinoids in Europe
Table 55. Current Situation and Forecast of Biosynthesis of Cannabinoids in Europe
Table 56. Key Companies of Biosynthesis of Cannabinoids in Asia-Pacific
Table 57. Current Situation and Forecast of Biosynthesis of Cannabinoids in Asia-Pacific
Table 58. Key Companies of Biosynthesis of Cannabinoids in China
Table 59. Key Companies of Biosynthesis of Cannabinoids in Japan
Table 60. Key Companies of Biosynthesis of Cannabinoids in South Korea
Table 61. Key Companies of Biosynthesis of Cannabinoids in South America
Table 62. Current Situation and Forecast of Biosynthesis of Cannabinoids in South America
Table 63. Key Companies of Biosynthesis of Cannabinoids in Middle East & Africa
Table 64. Current Situation and Forecast of Biosynthesis of Cannabinoids in Middle East & Africa
Table 65. Global Biosynthesis of Cannabinoids Revenue Forecast by Type (2024-2030)
Table 66. Global Biosynthesis of Cannabinoids Revenue Forecast by Application (2024-2030)

List Of Figures

LIST OF FIGURES

Figure 1. Biosynthesis of Cannabinoids Picture
Figure 2. Global Biosynthesis of Cannabinoids Revenue Market Share by Type in 2030
Figure 3. THC
Figure 4. CBD
Figure 5. Others
Figure 6. Biosynthesis of Cannabinoids Revenue Market Share by Application in 2030
Figure 7. Food Industry Picture
Figure 8. Medical Industry Picture
Figure 9. Others Picture
Figure 10. Global Biosynthesis of Cannabinoids Market Size, (USD Million): 2024 VS 2030
Figure 11. Global Biosynthesis of Cannabinoids Revenue and Forecast (2024-2030) & (USD Million)
Figure 12. Biosynthesis of Cannabinoids Market Drivers
Figure 13. Biosynthesis of Cannabinoids Market Restraints
Figure 14. Biosynthesis of Cannabinoids Market Trends
Figure 15. Anandia Laboratories Recent Developments and Future Plans
Figure 16. Gingko Bioworks Recent Developments and Future Plans
Figure 17. Hyasynth Bio Recent Developments and Future Plans
Figure 18. InMed Pharmaceuticals Recent Developments and Future Plans
Figure 19. Librede Recent Developments and Future Plans
Figure 20. Renew Biopharma Recent Developments and Future Plans
Figure 21. Cronos Group Recent Developments and Future Plans
Figure 22. Organigram Recent Developments and Future Plans
Figure 23. Teewinot Life Sciences Recent Developments and Future Plans
Figure 24. ICC International Cannabis Corp. Recent Developments and Future Plans
Figure 25. Biotii Technologies Corp. Recent Developments and Future Plans
Figure 26. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 27. Biogen Inc. Recent Developments and Future Plans
Figure 28. GW Pharmaceuticals Recent Developments and Future Plans
Figure 29. Global Biosynthesis of Cannabinoids Revenue Market Share by Region (2024-2030)
Figure 30. Global Biosynthesis of Cannabinoids Revenue Market Share by Region in 2030
Figure 31. North America Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2024-2030)
Figure 32. Europe Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2024-2030)
Figure 33. Asia-Pacific Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2024-2030)
Figure 34. South America Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2024-2030)
Figure 35. Middle East & Africa Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2024-2030)
Figure 36. Global Biosynthesis of Cannabinoids Market Share Forecast by Type (2024-2030)
Figure 37. Global Biosynthesis of Cannabinoids Market Share Forecast by Application (2024-2030)
Figure 38. Methodology
Figure 39. Research Process and Data Source